pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 43 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06441305: Expanding Coverage of Severe Acute Malnutrition (SAM) Treatment in Kenya

Sponsor: International Food Policy Research Institute. Phase: NA. Conditions: Acute Malnutrition, Severe, Malnutrition, Child, Wasting

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03484494: Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

Sponsor: Mclean Hospital. Phase: NA. Conditions: Bipolar Disorder, Bipolar Depression, Bipolar I Disorder, Bipolar II Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06029894: Improving Sleep and AD Biomarkers

Sponsor: Emory University. Phase: NA. Conditions: Mild Cognitive Impairment, Alzheimer Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04610866: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE1. Conditions: Sickle Cell Disease, Hemolytic Anemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07351851: Effects of PEMM in Chronic Low Back Pain Women With Urinary Incontinence

Sponsor: Hamad Medical Corporation. Phase: NA. Conditions: Chronic Low-back Pain (cLBP), Urinary Incontinence (UI), Pelvic External Myofascial Mobilisation, Myofascial Techniques, Pelvic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06044051: Dynamics of the Upper and Lower Airway Respiratory Microbiomes Associated With Severe Infant Asthma

Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Asthma in Children, Asthma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07333131: Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Iatrogenic Drug Events

full page →ctgov ↗
›RECRUITINGphase readoutNCT03794531: Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico

Sponsor: Harvard School of Public Health (HSPH). Phase: . Conditions: Heart Diseases, Type2 Diabetes, Hypertension, Obesity, Dyslipidemias, Metabolic Syndrome, Cardiovascular Diseases, Chronic Disease, Inflammation, Psychological Stress, Physiological Stress, Depressive Symptoms, Coping Behavior, Diet Habit, Lifestyle, Food Insecurity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06828822: CongenItal Naevus Cohort for Longitudinal Evaluation

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Naevi, Neurodevelopmental Disorder, Congenital Nevus

full page →ctgov ↗
›COMPLETEDphase readoutNCT02872051: Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and Depression

Sponsor: Amager Hospital. Phase: NA. Conditions: Generalized Anxiety, Social Phobia, Panic Disorder, Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT07293351: A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Advanced Renal Cell Carcinoma (RCC)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06824129: Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR

Sponsor: QIAGEN Gaithersburg, Inc. Phase: . Conditions: Complicated Urinary Tract Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT05329129: OssDsign® Spine Registry Study ("Propel")

Sponsor: OssDsign. Phase: . Conditions: Degenerative Disc Disease, Spinal Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06833853: A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients

Sponsor: Menarini Silicon Biosystems, INC. Phase: . Conditions: Metastatic Breast Cancer (MBC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT02356653: Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

Sponsor: Children's Hospital of Philadelphia. Phase: EARLY_PHASE1. Conditions: Leukemia, Inborn Errors of Metabolism, Bone Marrow Failure Syndromes, Immunodeficiencies, Immunodysregulation Polyendocrinopathy Enteropathy X-linked Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07407153: Triaging of Women Detected With a Breast Lump on Clinical Breast Examination Using Portable Ultrasound Device

Sponsor: International Agency for Research on Cancer. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07285837: Intensive Rehabilitation Program for Upper Limb in Children and Adolescents With Cerebral Palsy

Sponsor: Fondation Ellen Poidatz. Phase: NA. Conditions: Cerebral Palsy (CP)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06587737: Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage

Sponsor: Population Health Research Institute. Phase: PHASE3. Conditions: Colchicine, ICH - Intracerebral Hemorrhage, Stroke, Dependence

full page →ctgov ↗
›COMPLETEDphase readoutNCT03111745: Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Viral Infections

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07453095: Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

Sponsor: Fondazione Italiana Linfomi - ETS. Phase: PHASE2. Conditions: Mantle Cell Lymphoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07392801: AGE Accumulation in Patients on Long-term Parenteral Nutrition

Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Chronic Intestinal Insufficiency, Advanced Glycation and Products, Parenteral Nutrition

full page →ctgov ↗
›RECRUITINGphase readoutNCT06906601: Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.

Sponsor: Centre Leon Berard. Phase: . Conditions: Breast Cancer, Medico-economic Impact, Breast Cancer Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT05885412: A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Sponsor: Rocket Pharmaceuticals Inc.. Phase: PHASE1. Conditions: PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05711719: Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Metabolic Syndrome, Coronary Microvascular Dysfunction

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06929975: The Effect of Podcast Training on Birth Fear in Couples

Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Pregnancy, Birth Fear

full page →ctgov ↗
›RECRUITINGphase readoutNCT05806801: Metabolic Adaptations to Weight Loss With and Without Exercise

Sponsor: University of Michigan. Phase: NA. Conditions: Obesity, Metabolic Disease, Metabolic Syndrome, Insulin Sensitivity, Insulin Resistance, Weight Loss

full page →ctgov ↗
›COMPLETEDphase readoutNCT03847701: Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients

Sponsor: Mondelēz International, Inc.. Phase: NA. Conditions: Type2 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT07095712: Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS

Sponsor: n-Lorem Foundation. Phase: PHASE1. Conditions: Amyotrophic Lateral Sclerosis

full page →ctgov ↗
›TERMINATEDphase readoutNCT06068400: Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma

Sponsor: Guangzhou Bio-gene Technology Co., Ltd. Phase: NA. Conditions: Relapsed or Refractory Multiple Myeloma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07487207: Effects of Augmented Reality Functional Integrated Training (AR-FIT) on Balance and Mobility in Stroke

Sponsor: Riphah International University. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07578792: Standard vs Dual-Task Hand-Arm Bimanual Training in Post-Stroke Patients

Sponsor: Riphah International University. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT06785636: Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617

Sponsor: Pathos AI, Inc.. Phase: PHASE1. Conditions: mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Neoplasms, Male, Urogenital Neoplasms, Urogenital Cancers, Prostatic Diseases, Prostatic Neoplasms, Male Urogenital Diseases, Neoplasms, Neoplasms by Site, Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06170736: Radiofrequency Ablation vs Doppler-guided Haemorrhoidal Artery Ligation in the Treatment of Haemorrhoidal Disease

Sponsor: Centre Hospitalier Departemental Vendee. Phase: NA. Conditions: Haemorrhoids, Internal Haemorrhoids, Grade II/III Haemorrhoids

full page →ctgov ↗
›RECRUITINGphase readoutNCT06057181: Helix Research Network

Sponsor: Helix, Inc. Phase: . Conditions: Genetic Predisposition to Disease, Genetics Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06485219: A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd. Phase: PHASE2. Conditions: Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07334028: Study to Find Out the Timing for the Optimal Imaging of Varicose Veins Using Infrared Thermography.

Sponsor: The Whiteley Clinic. Phase: . Conditions: Varicose Veins Leg

full page →ctgov ↗
›RECRUITINGphase readoutNCT06980428: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants, Dyslipidemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06088628: Micro-expressions in Patients With Prolonged Disorders of Consciousness

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: . Conditions: Consciousness Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT07445867: Effectiveness Evaluation of a Comprehensive School Readiness Summer Program for Young Children At-Risk

Sponsor: Florida International University. Phase: NA. Conditions: Externalizing Behavior

full page →ctgov ↗
›RECRUITINGphase readoutNCT05584800: Study of ZGGS18 in Patients With Advanced Solid Tumors

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT06464107: Endometrial Cell Collection With the PadKit

Sponsor: Hackensack Meridian Health. Phase: NA. Conditions: Neoplasms

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07533136: Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax

Sponsor: Walter Reed Army Institute of Research (WRAIR). Phase: NA. Conditions: Uncomplicated P. Vivax Mono-infection

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06638671: Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity

Sponsor: University of Virginia. Phase: PHASE4. Conditions: Exercise Capacity, Metformin

full page →ctgov ↗
›RECRUITINGphase readoutNCT05748171: A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

Sponsor: Pfizer. Phase: PHASE2. Conditions: ACUTE LYMPHOBLASTIC LEUKEMIA

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06513871: Evaluating Social Perception Dynamics

Sponsor: Yale University. Phase: NA. Conditions: Mental Health Issue, COVID-19

full page →ctgov ↗
›RECRUITINGphase readoutNCT06496971: A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

Sponsor: NaviFUS Corporation. Phase: PHASE3. Conditions: Glioblastoma Multiforme, Glioblastoma, Glioblastoma Multiforme, Adult, Glioma, Brain Tumor, Brain Tumor, Recurrent, Neoplasms, Neoplasms, Nerve Tissue

full page →ctgov ↗
›RECRUITINGphase readoutNCT07317544: Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

Sponsor: Absci Pty Ltd.. Phase: PHASE1. Conditions: Androgenetic Alopecia (AGA), Healthy Volunteers - Male and Female

full page →ctgov ↗
›WITHDRAWNphase readoutNCT07474844: Structured TXI-RDI Integration for Endoscopic Resection

Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Polyp Colorectal, Endoscopic Mucosal Resection

full page →ctgov ↗
›COMPLETEDphase readoutNCT03904134: Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)

Sponsor: Center for International Blood and Marrow Transplant Research. Phase: NA. Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Acquired Aplastic Anemia, Sickle Cell Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07137481: Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Hematological Malignancies

full page →ctgov ↗
← prev
page 76 of 161
next →